Skip to content

Clinical trials

Epilepsies, Myoclonic trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Epilepsies, Myoclonic Clear all

92 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20122
20144
20158
20164
20176
20186
20194
20205
20218
20228
20235
20249
20258
20266

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed32
Recruiting13
Terminated12
Active, not recruiting9
Withdrawn6
Unknown status6
No longer available3
Approved for marketing3
Not yet recruiting3
Enrolling by invitation2
Available2
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jazz Pharmaceuticals7
Takeda7
Longboard Pharmaceuticals5
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.5
Encoded Therapeutics4
Fondazione Policlinico Universitario Agostino Gemelli IRCCS3
Gillette Children's Specialty Healthcare3
Stoke Therapeutics, Inc3
University of Colorado, Denver3
Amgen2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Epilepsies, Myoclonic92
Epilepsy33
Lennox Gastaut Syndrome26
Seizures18
Tuberous Sclerosis8
Brain Diseases5
Spasms, Infantile4
Drug Resistant Epilepsy3
Sudden Unexpected Death in Epilepsy3
Anemia, Sickle Cell2

Trials

Showing 1 to 25 of 92. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.